Our recent study uncovered a B-cell population that expands during tumor progression, marked by the surface receptor T-cell immunoglobulin and mucin domain 1 (TIM-1) and other T-cell checkpoint receptors, indicating that TIM-1 marks a subset of activated B cells expressing co-inhibitory molecules and IL-10. Here, HAVCR1 is linked to neoplasm.